• Dacarbazine Workflows for Cancer DNA Damage Research

  2026-09-24

  Build more interpretable Dacarbazine experiments by controlling fresh preparation, exposure, solvent, and assay timing. This practical guide distinguishes in-vitro cytotoxicity from clinical treatment and supportive-care outcomes across melanoma, lymphoma, and sarcoma research.

• SERCA2 Dysfunction, FABP4, and Atherosclerosis

  2026-09-23

  The reference study identifies the calcineurin/FoxO1/FABP4 pathway as a mechanistic link between SERCA2 dysfunction, altered fatty acid handling, macrophage foam cell formation, and atherosclerosis. Its combination of a SERCA2 C674S knock-in model, metabolomics, macrophage assays, pharmacological inhibition, and partial FABP4 deficiency supports FABP4 as an intervention point rather than a passive disease marker.

• Beclin1, Ferroptosis, and DOX Liver Injury

  2026-09-22

  The reference study identifies Beclin1 as a potentially harmful regulator of doxorubicin-induced liver injury by linking excessive autophagy with ferroptotic lipid damage. Its results position DHODH as a downstream protective component and show how combined assessment of oxidative stress, iron handling, lipid peroxidation, and pathway markers can clarify mechanism.

• MCL-1 Inhibition: From Apoptosis to Translation

  2026-09-22

  A mechanistic and translational framework for using MCL-1 inhibitor A-1210477 to interrogate cancer cell survival regulation, validate mitochondrial apoptosis, and distinguish target dependence from nonspecific cytotoxicity.

• GKT137831 at the Redox–Ferroptosis Interface

  2026-09-21

  A translational perspective on how dual Nox1/Nox4 inhibition can clarify oxidative stress biology, vascular remodeling, fibrosis, and emerging ferroptosis research without overstating the current evidence.

• ARID1A-Dependent Resistance in Melanoma

  2026-09-21

  This reference study uses integrative multi-omics and network analysis to define how ARID1A loss rewires early signaling responses to BRAF/MAPK inhibition in melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a framework for studying adaptive drug tolerance and immune-related changes beyond single-pathway measurements.

• TMEM16F Lipid Scrambling in Ferroptosis and Immunity

  2026-09-20

  Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as an execution-stage suppressor of ferroptosis. The study links failed membrane repair to lytic death, danger-signal release, slower tumor growth, and enhanced response to PD-1 blockade, providing a mechanistic bridge between membrane biophysics and tumor immunology.

• Masitinib (AB1010) KIT/PDGFR Workflow Guide

  2026-09-19

  Masitinib (AB1010) is a DMSO-compatible phenylaminothiazole-type tyrosine kinase inhibitor for focused studies of KIT, PDGFRα, PDGFRβ, mast cell behavior, and KIT-mutant tumor models. It is appropriate for defined in vitro or preclinical workflows, but should not be selected for aqueous or ethanol-based assays, broad-spectrum kinase suppression, or clinical use without separate regulatory and safety evaluation.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-09-19

  The reference study shows that dietary Arachidonic Acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its central mechanistic contribution is linking lymph-node arachidonate metabolism, prostaglandin I2 signaling, and germinal-center B-cell activity, while also identifying important questions about dose, safety, and transferability.

• VEGFC–Macrophage Signaling in NASH Fibrosis

  2026-09-18

  A 2026 Phytomedicine study identifies a hepatocyte-derived VEGFC–VEGFR-3–macrophage axis that promotes inflammation and fibrosis in high-fat diet-induced NASH. Pharmacological inhibition with SAR131675, hepatocyte-specific Vegfc deletion, and in vitro coculture experiments together indicate that this pathway regulates macrophage recruitment and Ly6Chigh-to-Ly6Clow phenotypic transition.

• Muscle BDNF and Early Neuromuscular Synapse Assembly

  2026-09-17

  Zhang and colleagues show that muscle-derived BDNF is trafficked to podosome-like structures, released in an activity- and calcium-dependent manner, and proteolytically processed to regulate the earliest organization of acetylcholine receptor clusters. By combining live imaging, targeted perturbations, nerve or agrin stimulation, and muscle-specific knockout mice, the study connects localized neurotrophin signaling with neuromuscular junction assembly in vitro and in vivo.

• PtrbZIP12 Links Phosphorylation to Poplar Drought Tolerance

  2026-09-17

  The reference study identifies PtrbZIP12 as a positive regulator of drought resistance in Populus trichocarpa and shows that it directly activates PtrDHN and PtrPOD. By connecting transcriptional regulation with phosphorylation-dependent control, the work provides a mechanistic framework for studying stress-responsive signal transduction in trees.

• S. eriocheiris Entry into Drosophila S2 Cells

  2026-09-17

  Wei and colleagues established a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris enters insect cells through clathrin-dependent endocytosis and macropinocytosis. Their inhibitor, cytoskeletal, and infection assays connect bacterial internalization with subsequent intracellular proliferation, vacuolization, and host-cell injury, providing a useful framework for mechanistic endocytosis research.

• DRB Workflows for Transcriptional Elongation

  2026-09-16

  Use DRB to create controlled transcriptional-elongation perturbations, separate RNA-synthesis effects from downstream translation changes, and troubleshoot cell-based assays with practical dose and timing controls. The workflow also shows how DRB can complement ac4C, RIC-seq, and Ribo-seq studies without being mistaken for an ac4C-specific reagent.

• 2-APB for Causal Calcium Signaling Studies

  2026-09-15

  2-APB, or 2-aminoethoxydiphenyl borate, is a versatile perturbation tool for separating IP3 receptor-mediated calcium release from store-operated calcium entry. This article develops a pathway-aware assay strategy that connects calcium phenotyping with the PLCβ3 mechanism reported in cardiovascular research.

8561 records 1/571 page Next 12345 下5页 Last page